GeneFerm Biotechnology Co (1796.TWO) Stock Price
GeneFerm Biotechnology Co Price
Over the last 12 years GeneFerm Biotechnology Co grew revenue by 9.8% annually, reaching 677.10 M TWD. Earnings per share have grown at 9.1% per year over the last 12 years. For GeneFerm Biotechnology Co, the net margin of 4.3% is down versus 11.0% a few years ago. At today's price the dividend yield works out to roughly 6.78%. The dividend has grown at 41.4% per year over the past 2 years.
GeneFerm Biotechnology Co stock price
GeneFerm Biotechnology Co business model & stock analysis
Frequently asked questions about GeneFerm Biotechnology Co
Converted at the current exchange rate, the GeneFerm Biotechnology Co share trades at 0.82 EUR (29.50 TWD).
The revenue cannot currently be calculated for GeneFerm Biotechnology Co.
The profit cannot currently be calculated for GeneFerm Biotechnology Co.
The P/E ratio cannot be calculated for GeneFerm Biotechnology Co at the moment.
The P/S cannot be calculated for GeneFerm Biotechnology Co currently.
The Eulerpool Quality Score for GeneFerm Biotechnology Co is 2/10.
The ISIN of GeneFerm Biotechnology Co is TW0001796001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of GeneFerm Biotechnology Co is 1796.TWO. The ticker symbol is used to trade GeneFerm Biotechnology Co shares on the stock exchange.
GeneFerm Biotechnology Co stock
GeneFerm Biotechnology Co Peer Group
GeneFerm Biotechnology Co FIGI
All fundamentals and in-depth analysis of GeneFerm Biotechnology Co
Our stock analysis for GeneFerm Biotechnology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GeneFerm Biotechnology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.